RhumbLine Advisers
AUPH icon

RhumbLine Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History

RhumbLine Advisers’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Buy
152,681
+10,097
+7% +$161K ﹤0.01% 1809
2026
Q1 		$2.11M Sell
142,584
-2,112
-1% -$30.9K ﹤0.01% 1824
2025
Q4 		$2.31M Sell
144,696
-26,443
-15% -$375K ﹤0.01% 1799
2025
Q3 		$1.89M Sell
171,139
-5,627
-3% -$61.5K ﹤0.01% 1944
2025
Q2 		$1.5M Sell
176,766
-16,969
-9% -$136K ﹤0.01% 2041
2025
Q1 		$1.56M Buy
193,735
+124
+0.1% +$1K ﹤0.01% 1944
2024
Q4 		$1.74M Sell
193,611
-180
-0.1% -$1.47K ﹤0.01% 1962
2024
Q3 		$1.42M Sell
193,791
-14,472
-7% -$89.7K ﹤0.01% 2084
2024
Q2 		$1.19M Buy
208,263
+24,371
+13% +$128K ﹤0.01% 2149
2024
Q1 		$921K Buy
183,892
+2,548
+1% +$17.3K ﹤0.01% 2297
2023
Q4 		$1.63M Buy
181,344
+664
+0.4% +$5.47K ﹤0.01% 2009
2023
Q3 		$1.4M Buy
180,680
+1,554
+0.9% +$15.2K ﹤0.01% 2027
2023
Q2 		$1.73M Buy
179,126
+5,624
+3% +$58.4K ﹤0.01% 1985
2023
Q1 		$1.9M Buy
173,502
+6,949
+4% +$61.2K ﹤0.01% 1831
2022
Q4 		$720K Buy
166,553
+2,672
+2% +$15.5K ﹤0.01% 2296
2022
Q3 		$1.23M Buy
163,881
+12,005
+8% +$104K ﹤0.01% 2028
2022
Q2 		$1.53M Buy
+151,876
New +$1.7M ﹤0.01% 1918

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RhumbLine Advisers's AUPH Position: Q2 2026 in Review

RhumbLine Advisers increased its Aurinia Pharmaceuticals (AUPH) stake by 7.1% in Q2 2026, buying an estimated $161K and bringing the position to 152,681 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

RhumbLine Advisers first reported a position in AUPH in Q2 2022 and has held it in 17 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • RhumbLine Advisers held 152,681 shares of Aurinia Pharmaceuticals worth $2.59M as of Q2 2026.
  • RhumbLine Advisers bought 10,097 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $161K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1809 holding.
  • RhumbLine Advisers first reported a position in Aurinia Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.